Suppr超能文献

具有抗SARS-CoV-2活性的天然产物及其衍生物的药理相关性与化学合成进展

An Update on Pharmacological Relevance and Chemical Synthesis of Natural Products and Derivatives with Anti SARS-CoV-2 Activity.

作者信息

Ahmad Irshad

机构信息

Department of Mathematics and Natural Sciences School of Arts and Sciences American University of Ras Al Khaimah Ras Al Khaimah Road, P. O. Box 10021 Ras Al Khaimah, UAE.

出版信息

ChemistrySelect. 2021 Nov 15;6(42):11502-11527. doi: 10.1002/slct.202103301. Epub 2021 Nov 8.

Abstract

Natural products recognized traditionally as a vital source of active constituents in pharmacotherapy. The COVID-19 infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly transmissible, pathogenic, and considered an ongoing global health emergency. The emergence of COVID-19 globally and the lack of adequate treatment brought attention towards herbal medicines, and scientists across the globe instigated the search for novel drugs from medicinal plants and natural products to tackle this deadly virus. The natural products rich in scaffold diversity and structural complexity are an excellent source for antiviral drug discovery. Recently the investigation of several natural products and their synthetic derivatives resulted in the identification of promising anti SARS-CoV-2 agents. This review article will highlight the pharmacological relevance and chemical synthesis of the recently discovered natural product and their synthetic analogs as SARS-CoV-2 inhibitors. The summarized information will pave the path for the natural product-based drug discovery of safe and potent antiviral agents, particularly against SARS-CoV-2.

摘要

天然产物传统上被认为是药物治疗中活性成分的重要来源。由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的2019冠状病毒病感染具有高度传染性和致病性,被视为持续的全球卫生紧急事件。2019冠状病毒病在全球的出现以及缺乏足够的治疗方法,使人们将注意力转向草药,全球科学家开始从药用植物和天然产物中寻找新型药物来对抗这种致命病毒。富含支架多样性和结构复杂性的天然产物是抗病毒药物发现的极佳来源。最近,对几种天然产物及其合成衍生物的研究导致了有前景的抗SARS-CoV-2药物的鉴定。这篇综述文章将重点介绍最近发现的天然产物及其合成类似物作为SARS-CoV-2抑制剂的药理学相关性和化学合成。总结的信息将为基于天然产物的安全有效抗病毒药物的发现铺平道路,特别是针对SARS-CoV-2的药物。

相似文献

7
Current Strategies of Antiviral Drug Discovery for COVID-19.新型冠状病毒肺炎抗病毒药物研发的当前策略
Front Mol Biosci. 2021 May 13;8:671263. doi: 10.3389/fmolb.2021.671263. eCollection 2021.

引用本文的文献

本文引用的文献

5
SARS-CoV-2 variants, spike mutations and immune escape.SARS-CoV-2 变体、刺突突变和免疫逃逸。
Nat Rev Microbiol. 2021 Jul;19(7):409-424. doi: 10.1038/s41579-021-00573-0. Epub 2021 Jun 1.
8
Long COVID: An overview.长新冠:概述。
Diabetes Metab Syndr. 2021 May-Jun;15(3):869-875. doi: 10.1016/j.dsx.2021.04.007. Epub 2021 Apr 20.
9
Post-acute COVID-19 syndrome.新冠病毒感染后长期综合征。
Nat Med. 2021 Apr;27(4):601-615. doi: 10.1038/s41591-021-01283-z. Epub 2021 Mar 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验